TreeWAS – Variant ID: rs7863100

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I74 Arterial embolism and thrombosis	0.000	0.766	0.234
I73.9 Peripheral vascular disease, unspecified	0.000	0.768	0.232
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.770	0.230
I73 Other peripheral vascular diseases	0.000	0.773	0.227
I74.5 Embolism and thrombosis of iliac artery	0.000	0.774	0.226
I77 Other disorders of arteries and arterioles	0.000	0.783	0.217
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.783	0.217
I77.1 Stricture of artery	0.000	0.788	0.212
I72 Other aneurysm	0.000	0.796	0.204
I74.8 Embolism and thrombosis of other arteries	0.000	0.797	0.203
I77.0 Arteriovenous fistula, acquired	0.000	0.820	0.179
I70 Atherosclerosis	0.000	0.826	0.174
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.826	0.174
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.827	0.173
I72.0 Aneurysm of carotid artery	0.000	0.830	0.170
I72.4 Aneurysm of artery of lower extremity	0.000	0.831	0.169
I72.9 Aneurysm of unspecified site	0.000	0.833	0.167
I77.8 Other specified disorders of arteries and arterioles	0.000	0.834	0.166
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.836	0.164
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.837	0.163
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.838	0.162
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.838	0.162
I73.8 Other specified peripheral vascular diseases	0.000	0.840	0.159
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.842	0.158
I77.5 Necrosis of artery	0.000	0.844	0.156
I77.4 Coeliac artery compression syndrome	0.000	0.844	0.156
I77.3 Arterial fibromuscular dysplasia	0.000	0.844	0.156
I72.8 Aneurysm of other specified arteries	0.000	0.853	0.147
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.854	0.146
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.854	0.146
I72.2 Aneurysm of renal artery	0.000	0.857	0.143
I72.3 Aneurysm of iliac artery	0.000	0.861	0.139
I70.1 Atherosclerosis of renal artery	0.000	0.865	0.135
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.865	0.135
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.866	0.134
I77.2 Rupture of artery	0.000	0.868	0.132
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.869	0.131
I72.1 Aneurysm of artery of upper extremity	0.000	0.870	0.130
I70.9 Generalised and unspecified atherosclerosis	0.000	0.875	0.125
I70.8 Atherosclerosis of other arteries	0.000	0.875	0.125
C91 Lymphoid leukaemia	0.125	0.875	0.000
I79.1 Aortitis in diseases classified elsewhere	0.000	0.876	0.124
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.000	0.876	0.124
C91.1 Chronic lymphocytic leukaemia	0.124	0.876	0.000
I77.6 Arteritis, unspecified	0.000	0.878	0.122
I71 Aortic aneurysm and dissection	0.000	0.878	0.122
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.879	0.121
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.120	0.880	0.000
I70.0 Atherosclerosis of aorta	0.000	0.887	0.113
C83 Diffuse non-Hodgkin's lymphoma	0.111	0.889	0.000
C83.0 Small cell (diffuse)	0.111	0.889	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.111	0.889	0.000
C91.5 Adult T-cell leukaemia	0.109	0.891	0.000
I78 Diseases of capillaries	0.000	0.893	0.107
C91.4 Hairy-cell leukaemia	0.107	0.893	0.000
I70.10 Atherosclerosis of renal artery (without gangrene)	0.000	0.893	0.107
C84 Peripheral and cutaneous T-cell lymphomas	0.106	0.894	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.895	0.104
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.102	0.898	0.000
C91.9 Lymphoid leukaemia, unspecified	0.101	0.899	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.099	0.901	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.902	0.098
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.903	0.097
C88 Malignant immunoproliferative diseases	0.095	0.905	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.095	0.905	0.000
C95 Leukaemia of unspecified cell type	0.094	0.906	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.906	0.094
C82.1 Mixed small cleaved and large cell, follicular	0.093	0.907	0.000
C82.0 Small cleaved cell, follicular	0.092	0.908	0.000
I71.0 Dissection of aorta [any part]	0.000	0.909	0.091
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.090	0.909	0.000
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.910	0.090
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.910	0.090
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.910	0.090
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.000	0.910	0.090
C91.8 Mature B-cell leukaemia Burkitt-type	0.090	0.910	0.000
C91.7 Other lymphoid leukaemia	0.090	0.910	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.090	0.910	0.000
C91.3 Prolymphocytic leukaemia	0.090	0.910	0.000
C91.2 Subacute lymphocytic leukaemia	0.090	0.910	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.910	0.090
C86 Other specified types of T/NK-cell lymphoma	0.089	0.911	0.000
C84.4 Peripheral T-cell lymphoma	0.088	0.912	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.912	0.088
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.912	0.088
I78.8 Other diseases of capillaries	0.000	0.913	0.087
I73.0 Raynaud's syndrome	0.000	0.913	0.087
C84.5 Other and unspecified T-cell lymphomas	0.086	0.914	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.086	0.914	0.000
C94 Other leukaemias of specified cell type	0.086	0.914	0.000
C93 Monocytic leukaemia	0.086	0.914	0.000
C83.1 Small cleaved cell (diffuse)	0.085	0.914	0.000
C82.2 Large cell, follicular	0.085	0.915	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.084	0.915	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.916	0.084
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.918	0.081
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.919	0.081
C83.6 Undifferentiated (diffuse)	0.080	0.920	0.000
C83.5 Lymphoblastic (diffuse)	0.080	0.920	0.000
C83.4 Immunoblastic (diffuse)	0.080	0.920	0.000
C83.2 Mixed small and large cell (diffuse)	0.080	0.920	0.000
C82.6 Cutaneous follicle centre lymphoma	0.080	0.920	0.000
C82.5 Diffuse follicle centre lymphoma	0.080	0.920	0.000
C82.4 Follicular lymphoma grade IIIb	0.080	0.920	0.000
C84.0 Mycosis fungoides	0.080	0.920	0.000
C91.0 Acute lymphoblastic leukaemia	0.079	0.921	0.000
C82.3 Follicular lymphoma grade IIIa	0.078	0.922	0.000
I78.9 Disease of capillaries, unspecified	0.000	0.923	0.077
C95.9 Leukaemia, unspecified	0.076	0.924	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.076	0.924	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.076	0.924	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.076	0.924	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.076	0.924	0.000
C84.3 Lymphoepithelioid lymphoma	0.076	0.924	0.000
C84.2 T-zone lymphoma	0.076	0.924	0.000
C84.1 Sezary's diease	0.076	0.924	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.074	0.926	0.000
C85.0 Lymphosarcoma	0.074	0.926	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.073	0.927	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.073	0.927	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.930	0.070
C90 Multiple myeloma and malignant plasma cell neoplasms	0.069	0.931	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.931	0.069
C88.9 Malignant immunoproliferative disease, unspecified	0.068	0.932	0.000
C88.7 Other malignant immunoproliferative diseases	0.068	0.932	0.000
C88.3 Immunoproliferative small intestinal disease	0.068	0.932	0.000
C88.2 Gamma heavy chain disease	0.068	0.932	0.000
C88.1 Alpha heavy chain disease	0.068	0.932	0.000
C95.7 Other leukaemia of unspecified cell type	0.068	0.932	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.068	0.932	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.068	0.932	0.000
C95.0 Acute leukaemia of unspecified cell type	0.068	0.932	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.068	0.932	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.067	0.933	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.935	0.065
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.064	0.936	0.000
C86.4 Blastic NK-cell lymphoma	0.064	0.936	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.064	0.936	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.064	0.936	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.064	0.936	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.064	0.936	0.000
C83.7 Burkitt's tumour	0.064	0.936	0.000
C92 Myeloid leukaemia	0.064	0.936	0.000
C93.9 Monocytic leukaemia, unspecified	0.062	0.938	0.000
C93.7 Other monocytic leukaemia	0.062	0.938	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.062	0.938	0.000
C93.2 Subacute monocytic leukaemia	0.062	0.938	0.000
C93.1 Chronic monocytic leukaemia	0.062	0.938	0.000
C93.0 Acute monocytic leukaemia	0.062	0.938	0.000
C94.7 Other specified leukaemias	0.062	0.938	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.062	0.938	0.000
C94.5 Acute myelofibrosis	0.062	0.938	0.000
C94.4 Acute panmyelosis	0.062	0.938	0.000
C94.3 Mast cell leukaemia	0.062	0.938	0.000
C94.2 Acute megakaryoblastic leukaemia	0.062	0.938	0.000
C94.1 Chronic erythraemia	0.062	0.938	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.062	0.938	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.062	0.938	0.000
C96.8 Histiocytic sarcoma	0.062	0.938	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.062	0.938	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.062	0.938	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.062	0.938	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.062	0.938	0.000
C96.3 True histiocytic lymphoma	0.062	0.938	0.000
C96.2 Malignant mast cell tumour	0.062	0.938	0.000
C96.1 Malignant histiocytosis	0.062	0.938	0.000
C96.0 Letterer-Siwe disease	0.062	0.938	0.000
C90.2 Plasmacytoma, extramedullary	0.058	0.942	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.057	0.943	0.000
C81 Hodgkin's disease	0.052	0.948	0.000
C90.1 Plasma cell leukaemia	0.049	0.950	0.000
C92.4 Acute promyelocytic leukaemia	0.047	0.952	0.000
C92.9 Myeloid leukaemia, unspecified	0.046	0.954	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.046	0.954	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.046	0.954	0.000
C92.5 Acute myelomonocytic leukaemia	0.046	0.954	0.000
C92.3 Myeloid sarcoma	0.046	0.954	0.000
C92.2 Subacute myeloid leukaemia	0.046	0.954	0.000
C90.3 Solitary plasmacytoma	0.045	0.955	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.955	0.045
I78.1 Naevus, nonneoplastic	0.000	0.956	0.044
C92.7 Other myeloid leukaemia	0.044	0.956	0.000
C81.7 Other Hodgkin's disease	0.040	0.960	0.000
C92.1 Chronic myeloid leukaemia	0.040	0.960	0.000
C83.3 Large cell (diffuse)	0.040	0.960	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.037	0.962	0.000
C81.3 Lymphocytic depletion	0.037	0.962	0.000
C81.2 Mixed cellularity	0.036	0.963	0.000
C81.0 Lymphocytic predominance	0.036	0.963	0.000
C92.0 Acute myeloid leukaemia	0.036	0.964	0.000
C85.1 B-cell lymphoma, unspecified	0.034	0.966	0.000
C81.1 Nodular sclerosis	0.033	0.967	0.000
Y86 Sequelae of other accidents	0.027	0.973	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.018	0.982	0.000
C90.0 Multiple myeloma	0.017	0.983	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.016	0.984	0.000
Y87.1 Sequelae of assault	0.014	0.985	0.000
Y85 Sequelae of transport accidents	0.014	0.985	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.014	0.986	0.000
Y88 Sequelae of surgical and medical care as external cause	0.014	0.986	0.000
Y87.2 Sequelae of events of undetermined intent	0.013	0.987	0.000
M17.1 Other primary gonarthrosis	0.000	0.987	0.013
M17.0 Primary gonarthrosis, bilateral	0.000	0.987	0.013
Y89 Sequelae of other external causes	0.012	0.987	0.000
C81.9 Hodgkin's disease, unspecified	0.011	0.988	0.001
Y87.0 Sequelae of intentional self-harm	0.012	0.988	0.000
T39.0 Salicylates	0.000	0.989	0.011
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.011	0.989	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.989	0.011
C43.3 Malignant melanoma of other and unspecified parts of face	0.010	0.990	0.000
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.010	0.990	0.000
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.010	0.990	0.000
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.010	0.990	0.000
T39.1 4-Aminophenol derivatives	0.000	0.990	0.010
M17 Gonarthrosis [arthrosis of knee]	0.000	0.990	0.010
Y89.1 Sequelae of war operations	0.009	0.991	0.000
Y89.0 Sequelae of legal intervention	0.009	0.991	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.991	0.009
T40.2 Other opioids	0.000	0.991	0.009
Y89.9 Sequelae of unspecified external cause	0.008	0.992	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.992	0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.992	0.008
T39.4 Antirheumatics, not elsewhere classified	0.000	0.992	0.008
T39.2 Pyrazolone derivatives	0.000	0.992	0.008
M17.3 Other posttraumatic gonarthrosis	0.000	0.993	0.007
M17.4 Other secondary gonarthrosis, bilateral	0.000	0.993	0.007
M17.2 Posttraumatic gonarthrosis, bilateral	0.000	0.993	0.007
K62.8 Other specified diseases of anus and rectum	0.007	0.993	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.993	0.007
M17.5 Other secondary gonarthrosis	0.000	0.993	0.007
M93.9 Osteochondropathy, unspecified	0.000	0.993	0.007
E87.1 Hypo-osmolality and hyponatraemia	0.007	0.993	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.994	0.006
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.000	0.994	0.006
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.995	0.005
T40.8 Lysergide [LSD]	0.000	0.995	0.005
T40.7 Cannabis (derivatives)	0.000	0.995	0.005
T40.5 Cocaine	0.000	0.995	0.005
T40.4 Other synthetic narcotics	0.000	0.995	0.005
T40.3 Methadone	0.000	0.995	0.005
T40.1 Heroin	0.000	0.995	0.005
T40.0 Opium	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
T40.6 Other and unspecified narcotics	0.000	0.995	0.005
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
T46.1 Calcium-channel blockers	0.000	0.995	0.005
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
Y85.0 Sequelae of motor-vehicle accident	0.005	0.995	0.000
G56.2 Lesion of ulnar nerve	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.000	0.995	0.004
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
M93 Other osteochondropathies	0.000	0.996	0.004
D32.9 Meninges, unspecified	0.004	0.996	0.000
G40.5 Special epileptic syndromes	0.004	0.996	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
O34.8 Maternal care for other abnormalities of pelvic organs	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.004
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.004
T50.5 Appetite depressants	0.000	0.996	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T81.8 Other complications of procedures, not elsewhere classified	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
T36.0 Penicillins	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.003
T41.4 Anaesthetic, unspecified	0.000	0.996	0.003
T41.3 Local anaesthetics	0.000	0.996	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.003
T41.1 Intravenous anaesthetics	0.000	0.996	0.003
T41.0 Inhaled anaesthetics	0.000	0.996	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.003
T48.5 Anti-common-cold drugs	0.000	0.996	0.003
T48.4 Expectorants	0.000	0.996	0.003
T48.3 Antitussives	0.000	0.996	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.003
T48.0 Oxytocic drugs	0.000	0.996	0.003
T49.9 Topical agent, unspecified	0.000	0.996	0.003
T49.8 Other topical agents	0.000	0.996	0.003
T49.7 Dental drugs, topically applied	0.000	0.996	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.003
T49.2 Local astringents and local detergents	0.000	0.996	0.003
T49.1 Antipruritics	0.000	0.996	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.003
T44.0 Anticholinesterase agents	0.000	0.996	0.003
G40 Epilepsy	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
T36.6 Rifamycins	0.000	0.996	0.003
T36.5 Aminoglycosides	0.000	0.996	0.003
T36.4 Tetracyclines	0.000	0.996	0.003
T36.3 Macrolides	0.000	0.996	0.003
T36.2 Chloramphenicol group	0.000	0.996	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.997	0.003
I95.2 Hypotension due to drugs	0.000	0.997	0.003
M93.8 Other specified osteochondropathies	0.000	0.997	0.003
M93.2 Osteochondritis dissecans	0.000	0.997	0.003
M93.1 Kienbock's disease of adults	0.000	0.997	0.003
M93.0 Slipped upper femoral epiphysis (nontraumatic)	0.000	0.997	0.003
I08.0 Disorders of both mitral and aortic valves	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
J30.1 Allergic rhinitis due to pollen	0.000	0.997	0.003
R01.1 Cardiac murmur, unspecified	0.000	0.997	0.003
J30.3 Other allergic rhinitis	0.000	0.997	0.003
G43.1 Migraine with aura [classical migraine]	0.003	0.997	0.000
G40.8 Other epilepsy	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
G43.9 Migraine, unspecified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
G43 Migraine	0.003	0.997	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.003	0.997	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.003	0.997	0.000
H60.8 Other otitis externa	0.003	0.997	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
C43.9 Malignant melanoma of skin, unspecified	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.002
Z48.9 Surgical follow-up care, unspecified	0.003	0.997	0.000
M93.26 Osteochondritis dissecans knee	0.000	0.997	0.002
M93.86 Other specified osteochondropathies, lower leg	0.000	0.997	0.002
T45.5 Anticoagulants	0.000	0.997	0.003
J30 Vasomotor and allergic rhinitis	0.000	0.997	0.003
G43.0 Migraine without aura [common migraine]	0.003	0.997	0.000
T47.4 Other laxatives	0.000	0.997	0.002
Z46.6 Fitting and adjustment of urinary device	0.003	0.997	0.000
D59.1 Other autoimmune haemolytic anaemias	0.000	0.997	0.003
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.002
K12.3 Oral mucositis (ulcerative)	0.002	0.997	0.000
C17.9 Small intestine, unspecified	0.000	0.998	0.002
G43.8 Other migraine	0.002	0.998	0.000
J30.4 Allergic rhinitis, unspecified	0.000	0.998	0.002
J30.0 Vasomotor rhinitis	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
C43 Malignant melanoma of skin	0.002	0.998	0.000
M91-M94 Chondropathies	0.000	0.998	0.002
G43.3 Complicated migraine	0.002	0.998	0.000
G43.2 Status migrainosus	0.002	0.998	0.000
M92 Other juvenile osteochondrosis	0.000	0.998	0.002
E06.3 Autoimmune thyroiditis	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
D22.4 Melanocytic naevi of scalp and neck	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
M92.7 Juvenile osteochondrosis of metatarsus	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.002	0.998	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.002	0.998	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.998	0.002
C43.2 Malignant melanoma of ear and external auricular canal	0.002	0.998	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.998	0.002
Z89.5 Acquired absence of leg at or below knee	0.000	0.998	0.002
D59.9 Acquired haemolytic anaemia, unspecified	0.000	0.998	0.002
M92.6 Juvenile osteochondrosis of tarsus	0.000	0.998	0.002
C43.8 Overlapping malignant melanoma of skin	0.002	0.998	0.000
C43.0 Malignant melanoma of lip	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
Z42.1 Follow-up care involving plastic surgery of breast	0.002	0.998	0.000
D59 Acquired haemolytic anaemia	0.000	0.998	0.002
H60 Otitis externa	0.002	0.998	0.000
C17.0 Duodenum	0.000	0.998	0.002
C43.6 Malignant melanoma of upper limb, including shoulder	0.002	0.998	0.000
M92.5 Juvenile osteochondrosis of tibia and fibula	0.000	0.998	0.002
M92.1 Juvenile osteochondrosis of radius and ulna	0.000	0.998	0.002
M92.9 Juvenile osteochondrosis, unspecified	0.000	0.998	0.002
M92.8 Other specified juvenile osteochondrosis	0.000	0.998	0.002
M92.4 Juvenile osteochondrosis of patella	0.000	0.998	0.002
M92.3 Other juvenile osteochondrosis of upper limb	0.000	0.998	0.002
M92.2 Juvenile osteochondrosis of hand	0.000	0.998	0.002
M92.0 Juvenile osteochondrosis of humerus	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
D46.2 Refractory anaemia with excess of blasts	0.002	0.998	0.000
N60.2 Fibroadenosis of breast	0.002	0.998	0.000
M94 Other disorders of cartilage	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
M91 Juvenile osteochondrosis of hip and pelvis	0.000	0.998	0.002
C43.1 Malignant melanoma of eyelid, including canthus	0.002	0.998	0.000
J38.7 Other diseases of larynx	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
D32 Benign neoplasm of meninges	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
I97.2 Postmastectomy lymphoedema syndrome	0.000	0.998	0.002
M94.2 Chondromalacia	0.000	0.998	0.002
M94.26 Chondromalacia (Lower leg)	0.000	0.998	0.002
D46 Myelodysplastic syndromes	0.002	0.998	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.998	0.002
H60.2 Malignant otitis externa	0.002	0.998	0.000
N90.5 Atrophy of vulva	0.000	0.998	0.002
C17 Malignant neoplasm of small intestine	0.000	0.998	0.002
D46.1 Refractory anaemia with sideroblasts	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.002	0.998	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.002	0.998	0.000
Q05.9 Spina bifida, unspecified	0.000	0.998	0.002
S79.9 Unspecified injury of hip and thigh	0.002	0.998	0.000
D46.4 Refractory anaemia, unspecified	0.002	0.998	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.002	0.998	0.000
K74.3 Primary biliary cirrhosis	0.002	0.998	0.000
D59.8 Other acquired haemolytic anaemias	0.000	0.998	0.002
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.000	0.998	0.002
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.000	0.998	0.002
D59.4 Other nonautoimmune haemolytic anaemias	0.000	0.998	0.002
D59.3 Haemolytic-uraemic syndrome	0.000	0.998	0.002
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.000	0.998	0.002
D59.0 Drug-induced autoimmune haemolytic anaemia	0.000	0.998	0.002
H50.0 Convergent concomitant strabismus	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
H60.0 Abscess of external ear	0.002	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.002	0.998	0.000
M92.10 Juvenile osteochondrosis of radius and ulna, unspecified arm	0.000	0.998	0.001
M92.51 Juvenile osteochondrosis of tibia and fibula, right leg	0.000	0.998	0.001
M92.50 Juvenile osteochondrosis of tibia and fibula, unspecified leg	0.000	0.998	0.001
C17.2 Ileum	0.000	0.998	0.002
M91.2 Coxa plana	0.000	0.998	0.001
M94.3 Chondrolysis	0.000	0.998	0.001
M94.1 Relapsing polychondritis	0.000	0.998	0.001
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.998	0.001
D32.0 Cerebral meninges	0.002	0.998	0.000
M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified	0.000	0.998	0.001
M91.8 Other juvenile osteochondrosis of hip and pelvis	0.000	0.998	0.001
M91.3 Pseudocoxalgia	0.000	0.998	0.001
M91.0 Juvenile osteochondrosis of pelvis	0.000	0.998	0.001
W44.0 Home	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations